CVR number 41817607
Industry 32.5000 Manufacture of medical and dental instruments and supplies

CFN Medico ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  0.0% 0.0% 9.6% 9.2% 9.3%  
Credit score (0-100)  0 0 24 26 25  
Credit rating  N/A N/A BB BB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -387 68.9 5.9  
EBITDA  0.0 0.0 -387 68.9 5.9  
EBIT  0.0 0.0 -387 68.9 5.9  
Pre-tax profit (PTP)  0.0 0.0 -388.6 68.7 6.0  
Net earnings  0.0 0.0 -303.1 53.6 4.7  
Pre-tax profit without non-rec. items  0.0 0.0 -389 68.7 6.0  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 -263 -210 -205  
Interest-bearing liabilities  0.0 0.0 728 758 758  
Balance sheet total (assets)  0.0 0.0 465 549 585  
Net Debt  0.0 0.0 714 718 577  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -387 68.9 5.9  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -91.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 465 549 585  
Balance sheet change%  0.0% 0.0% 0.0% 18.0% 6.6%  
Added value  0.0 0.0 -387.2 68.9 5.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 1.0 2.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -53.2% 9.3% 0.8%  
ROI %  0.0% 0.0% -53.2% 9.3% 0.8%  
ROE %  0.0% 0.0% -65.1% 10.6% 0.8%  

Solidity 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  0.0% 0.0% -36.1% -27.6% -25.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -184.5% 1,041.0% 9,759.5%  
Gearing %  0.0% 0.0% -276.8% -362.0% -370.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.4% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  0.0 0.0 0.2 0.2 0.3  
Current Ratio  0.0 0.0 0.6 0.7 0.7  
Cash and cash equivalent  0.0 0.0 14.2 40.8 181.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -263.1 -209.5 -204.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0